Neovasc Inc.
(NASDAQ : NVCN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading NVCN News...
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
BCRC. R. Bard, Inc.
0.73%307.821.6%$420.79m
ABTAbbott Laboratories
0.00%43.650.8%$303.99m
ISRGIntuitive Surgical, Inc.
-0.08%835.877.5%$303.78m
MDTMedtronic PLC
-0.06%83.080.6%$300.49m
BDXBecton, Dickinson and Company
2.47%187.061.3%$288.66m
TMOThermo Fisher Scientific Inc.
-0.85%165.281.0%$272.30m
BSXBoston Scientific Corporation
0.78%26.391.1%$204.45m
BAXBaxter International Inc.
0.47%55.681.7%$202.35m
EWEdwards Lifesciences Corporation
0.01%109.681.2%$201.37m
SYKStryker Corporation
0.74%136.371.3%$138.99m
ZBHZimmer Biomet Holdings, Inc.
1.27%119.601.7%$132.37m
ALGNAlign Technology, Inc.
12.10%134.626.2%$109.43m
HOLXHologic, Inc.
1.28%45.151.6%$99.88m
VARVarian Medical Systems, Inc.
1.97%90.778.8%$98.62m
IDXXIDEXX Laboratories, Inc.
3.05%167.733.7%$95.19m

Company Profile

Neovasc, Inc. operates as a medical device company that develops, manufactures, and markets products for the rapidly growing cardiovascular device marketplace. Its products include the Neovasc Reducer for the treatment of refractory angina and the Tiara technology in development for the transcatheter treatment of mitral valve disease. It operates through the following geographical segments: U.S., Europe, and the Rest of the World. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada.